SA17. Response to Treatment With Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia

Background: Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder resulting from exposure to dopamine receptor-blocking agents (DRBAs), such as antipsychotics. Valbenazine is a novel and highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor that is being...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Schizophr Bull
Egile Nagusiak: Kane, John, Josiassen, Richard, Burke, Joshua, Jimenez, Roland, Siegert, Scott, Liang, Grace
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475908/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx023.016
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak